Hypoactive Sexual Desire Disorder and current pharmacotherapeutic options in women

被引:20
作者
Palacios, Santiago [1 ]
机构
[1] Palacios Inst Womans Hlth, Antonio Acuna,9, S-28009 Madrid, Spain
关键词
androgens; cognitive behavioral therapy; DHEA; diagnosis; estrogens; flibanserine; Hypoactive Sexual Desire Disorder; new strategies; physiopathology; testosterone;
D O I
10.2217/WHE.10.81
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Hypoactive Sexual Desire Disorder (HSDD) is the most common female sexual dysfunction. The diagnosis of HSDD requires the existence of personal distress or interpersonal difficulties associated with low sexual desire, that cannot be explained by any other psychiatric affection and that is not exclusively due to a disease or substance. HSDD can have a serious effect on emotional wellbeing and interpersonal relationships, and it occurs in premenopausal and postmenopausal women. The Decreased Sexual Desire Screener is a shortened diagnostic method designed to help doctors who are not specialized in female sexual dysfunction to diagnose acquired HSDD in women. There is evidence that treatment with androgens or with estrogens is effective in HSDD; however, important unanswered questions still exist. Presently, new therapeutic strategies to combat HSDD are being researched, including novel methods of testosterone provision and drugs that act upon the CNS.
引用
收藏
页码:95 / 107
页数:13
相关论文
共 70 条
[1]   Therapeutic options for postmenopausal female sexual dysfunction [J].
Al-Azzawi, F. ;
Bitzer, J. ;
Brandenburg, U. ;
Castelo-Branco, C. ;
Graziottin, A. ;
Kenemans, P. ;
Lachowsky, M. ;
Mimoun, S. ;
Nappi, R. E. ;
Palacios, S. ;
Schwenkhagen, A. ;
Studd, J. ;
Wylie, K. ;
Zahradnik, H. -P. .
CLIMACTERIC, 2010, 13 (02) :103-120
[2]  
American Psychiatric Association, 1987, DIAGNOSTIC STAT MANU, V3rd
[3]  
American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th., DOI DOI 10.1176/APPI.BOOKS.9780890425787
[4]  
American Psychiatric Association
[5]  
Committee on Nomenclature and Statistics, 1968, DIAGN STAT MAN MENT
[6]  
[Anonymous], 2006, INTRINSA SUMMARY PRO
[7]   Dehydroepiandrosterone replacement in women with adrenal insufficiency [J].
Arlt, W ;
Callies, F ;
van Vlijmen, JC ;
Koehler, I ;
Reincke, M ;
Bidlingmaier, M ;
Huebler, D ;
Oettel, M ;
Ernst, M ;
Schulte, HM ;
Allolio, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (14) :1013-1020
[8]   Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment [J].
Bachmann, G ;
Bancroft, J ;
Braunstein, G ;
Burger, H ;
Davis, S ;
Dennerstein, L ;
Goldstein, I ;
Guay, A ;
Leiblum, S ;
Lobo, R ;
Notelovitz, M ;
Rosen, R ;
Sarrel, P ;
Sherwin, B ;
Simon, J ;
Simpson, E ;
Shifren, J ;
Spark, R ;
Traish, A .
FERTILITY AND STERILITY, 2002, 77 (04) :660-665
[9]   PROSPECTIVE-STUDY OF ENDOGENOUS SEX-HORMONES AND FATAL CARDIOVASCULAR-DISEASE IN POSTMENOPAUSAL WOMEN [J].
BARRETTCONNOR, E ;
GOODMANGRUEN, D .
BRITISH MEDICAL JOURNAL, 1995, 311 (7014) :1193-1196
[10]   Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications [J].
Basson, R ;
Berman, J ;
Burnett, A ;
Derogatis, L ;
Ferguson, D ;
Fourcroy, J ;
Goldstein, I ;
Graziottin, A ;
Heiman, J ;
Laan, E ;
Leiblum, S ;
Padma-Nathan, H ;
Rosen, R ;
Segraves, K ;
Segraves, RT ;
Shabsigh, R ;
Sipski, M ;
Wagner, G ;
Whipple, B .
JOURNAL OF UROLOGY, 2000, 163 (03) :888-893